Home > Insider Trading > Filing (0001104659-22-114089)

Filing Details

Accession Number:: 0001104659-22-114089
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-11-02 19:41:03
Reporting Period:: 2022-10-31

Accepted Time:: 2022-11-02 19:41:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1856725	Rani Therapeutics Holdings Inc.	RANI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1854578	Alfonso Isidoro Cortes Quiroga	Leonel Aguirre 1830, Apartment 101 Montevideo X3 11500		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2022-10-31	16,523	$6.11	5,218,821	No	4	P	Indirect	Shares indirectly held through Aequanimitas Limited Partnership
Class A Common Stock	Acquisiton	2022-11-01	3,768	$5.98	5,222,589	No	4	P	Indirect	Shares indirectly held through Aequanimitas Limited Partnership
Class A Common Stock	Acquisiton	2022-11-02	25,197	$6.31	5,247,786	No	4	P	Indirect	Shares indirectly held through Aequanimitas Limited Partnership

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Shares indirectly held through Aequanimitas Limited Partnership
No	4	P	Indirect	Shares indirectly held through Aequanimitas Limited Partnership
No	4	P	Indirect	Shares indirectly held through Aequanimitas Limited Partnership

Footnotes

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.98 to $6.14 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.96 to $6.22 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.01 to $6.50 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
Isidoro Alfonso Quiroga Cortes directly owns 100% of the issued and outstanding interest of the Aequanimitas Management LLC (the "General Partner"). The General Partner directly controls Aequanimitas Limited Partnership ("Aequanimitas") as its general partner with the power to manage Aequanimitas. Quiroga Cortes is the sole limited partner of Aequanimitas.